Patents Assigned to EGIS PHARMACEUTICALS PLC
  • Transdermal formulation containing COX inhibitors
    Patent number: 11154535
    Abstract: Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: October 26, 2021
    Assignee: EGIS Pharmaceuticals PLC
    Inventors: Endre Mikulásik, Tamás Spaits, Ágota Szakálynè Sinka
  • Transdermal formulation containing COX inhibitors
    Patent number: 10045965
    Abstract: Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: August 14, 2018
    Assignee: EGIS Pharmaceuticals PLC
    Inventors: Endre Mikulásik, Tamás Spaits, Ágota Szakályné Sinka
  • Transdermal formulation containing COX inhibitors
    Patent number: 10045935
    Abstract: Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: August 14, 2018
    Assignee: EGIS PHARMACEUTICALS PLC
    Inventors: Endre Mikulásik, Tamás Spaits, Ágota Szakályné Sinka
  • TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS
    Publication number: 20140161889
    Abstract: Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.
    Type: Application
    Filed: February 13, 2014
    Publication date: June 12, 2014
    Applicant: EGIS PHARMACEUTICALS PLC
    Inventors: Endre Mikulásik, Tamás Spaits, Ágota Szakálynè Sinka
  • TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS
    Publication number: 20140037738
    Abstract: Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.
    Type: Application
    Filed: July 31, 2012
    Publication date: February 6, 2014
    Applicant: EGIS PHARMACEUTICALS PLC
    Inventors: Endre MIKULÁSIK, Tamás SPAITS, Ágota SZAKÁLYNÉ SINKA
  • TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS
    Publication number: 20140039028
    Abstract: Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound.
    Type: Application
    Filed: September 13, 2013
    Publication date: February 6, 2014
    Applicant: EGIS Pharmaceuticals PLC
    Inventors: Endre Mikulásik, Tamás Spaits, Ágota Szakálynè Sinka
  • Prasugrel containing quickly released stable oral pharmaceutical compositions
    Patent number: 8603537
    Abstract: Prasugrel containing quickly released stable oral pharmaceutical compositions containing micronized prasugrel base, and starch or a starch derivative, and processes for the preparation thereof, and the use thereof for treating atherothrombotic events of patients suffering from acute coronary syndrome in which patients were subjected to percutaneous coronary intervention.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: December 10, 2013
    Assignee: Egis Pharmaceuticals PLC
    Inventors: András Fehér, Zsolt Zsigmong, Péter Tonka-Nagy, György Tibor Ujfalussy
  • PRASUGREL CONTAINING QUICKLY RELEASED STABLE ORAL PHARMACEUTICAL COMPOSITIONS
    Publication number: 20130259904
    Abstract: Prasugrel containing quickly released stable oral pharmaceutical compositions containing micronized prasugrel base, and starch or a starch derivative, and processes for the preparation thereof, and the use thereof for treating atherothrombotic events of patients suffering from acute coronary syndrome in which patients were subjected to percutaneous coronary intervention.
    Type: Application
    Filed: April 2, 2012
    Publication date: October 3, 2013
    Applicant: EGIS PHARMACEUTICALS PLC
    Inventors: András FEHÉR, Zsolt Zsigmond, Péter Tonka-Nagy, György Tibor Ujfalussy